| Name | (5s,12r)-5,12,20-trihydroxy-(6z,8e,10e,14z)-eicosatetraenoic acid | 
|---|---|
| Synonyms | 20-hydroxy-leukotriene B4 20-Hydroxy-LTB4 20-hydroxyleukotriene hydroxyleukotriene B4 (5S,6Z,8E,10E,12R,14Z)-5,12,20-Trihydroxy-6,8,10,14-icosatetraenoic acid LTB4_20-hydroxy 20-OH-LTB4 5S,12R,20-TRIHYDROXY-6Z,8E,10E,14Z-EICOSATETRAENOIC ACID 6,8,10,14-Eicosatetraenoic acid, 5,12,20-trihydroxy-, (5S,6Z,8E,10E,12R,14Z)- MFCD00065858 | 
| Description | 20-Hydroxy-leukotriene B4 is an endogenous metabolite present in Urine that can be used for the research of Sjogren Larsson Syndrome[1][2]. | 
|---|---|
| Related Catalog | |
| Target | Human Endogenous Metabolite | 
| In Vitro | Endogenous metabolites is defined as those that are annotated by Kyoto Encyclopedia of Genes and Genomes as substrates or products of the ~1900 metabolic enzymes encoded in our genome. It is clear in the body of literature that there are documented toxic properties for many of these metabolites[1]. | 
| References | 
| Density | 1.1±0.1 g/cm3 | 
|---|---|
| Boiling Point | 581.8±50.0 °C at 760 mmHg | 
| Molecular Formula | C20H32O5 | 
| Molecular Weight | 352.465 | 
| Flash Point | 319.7±26.6 °C | 
| Exact Mass | 352.224976 | 
| PSA | 97.99000 | 
| LogP | 2.05 | 
| Vapour Pressure | 0.0±3.7 mmHg at 25°C | 
| Index of Refraction | 1.542 | 
| Hazard Codes | F: Flammable;Xi: Irritant; | 
|---|---|
| Risk Phrases | 11-36/37/38 | 
| Safety Phrases | 16-26-36 | 
| RIDADR | UN 1170 3/PG 2 | 
| Precursor 8 | |
|---|---|
| DownStream 0 | |